Skip to main content
logo
Jagsonpal Pharmaceuticals Limited (BOM:507789)
India flag India · Delayed Price · Currency is INR
210.30
+1.45 (0.69%)
At close: Apr 30, 2026

Jagsonpal Pharmaceuticals Revenue

In the fiscal year ending March 31, 2026, Jagsonpal Pharmaceuticals had annual revenue of 2.99B INR with 11.35% growth. Jagsonpal Pharmaceuticals had revenue of 761.98M in the quarter ending March 31, 2026, with 30.12% growth.

Revenue
2.99B
Revenue Growth
+11.35%
P/S Ratio
4.72
Revenue / Employee
2.14M
Employees
1,399
Market Cap
14.12B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 20262.99B305.04M11.35%
Mar 31, 20252.69B600.14M28.76%
Mar 31, 20242.09B-280.12M-11.83%
Mar 31, 20232.37B191.30M8.79%
Mar 31, 20222.18B296.38M15.77%
Mar 31, 2021 Pro Pro Pro
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Apr 1, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
IOL Chemicals and Pharmaceuticals22.27B
Shilpa Medicare14.33B
Bajaj HealthCare6.12B
NGL Fine-Chem4.47B
Aarey Drugs & Pharmaceuticals3.91B
Anlon Healthcare1.70B
Sai Parenteral's1.63B
Gujarat Themis Biosyn1.59B
Revenue Rankings

Jagsonpal Pharmaceuticals News

More News